Position in ARQT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$9,748,939
+$3,222,490 QoQ
Shares Held
413,792
+84.1% QoQ
Ownership
0.331%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 91.89133671023123.ToString("F0")%
Shared 0.ToString("F0")%
None 8.108663289768772.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Derivatives in ARQT
reported options exposure · as of Mar 31, 2025CallValue
$1,564,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEMPOINT CAPITAL LP holds $493,288,963 across 62 Biotechnology names. ARQT ranks #15 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
1,035,496 | $50,904,983 | |
| 2 | ABVX |
Abivax S.A.
|
313,791 | $34,940,627 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,215,743 | $28,399,756 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
281,632 | $27,388,712 | |
| 5 | IMVT |
Immunovant, Inc.
|
746,494 | $18,542,910 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
56,267 | $18,128,664 | |
| 7 | SRZN |
Surrozen, Inc./DE
|
525,639 | $15,311,863 | |
| 8 | MBX |
MBX Biosciences, Inc.
|
499,469 | $14,909,149 |
All Filings in ARQT
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,748,939 | 413,792 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $6,526,449 | 224,740 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,764,183 | 411,893 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,883,521 | 205,672 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,882,741 | 440,073 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $1,564,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $21,939,750 | 1,575,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $6,978,456 | 500,966 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,538,357 | 1,778,318 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $2,325,000 | 250,000 | Call | Sole | 2024-11-13 | |
| 2024-06-30 | $8,978,145 | 965,392 | Shares | Sole | 2024-08-13 | |
| 2024-06-30 | $4,650,000 | 500,000 | Call | Sole | 2024-08-13 | |
| 2024-03-31 | $21,860,459 | 2,205,899 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,175,750 | 825,000 | Put | Sole | 2024-08-09 | |
| 2023-12-31 | $8,380,351 | 2,594,536 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||